Abstract
Background: Transcatheter aortic valve implantation (TAVI) is aortic annuli >29 mm represent a special technical challenge since common balloon-expandable (BE) transcatheter heart valves (THV) are approved for aortic annuli ≤29 mm. However, treatment of aortic annuli above this limit is possible by overfilling of the deployment balloon of the most common BE THV. The aim of this study was to analyze outcomes of patients undergoing TAVI using BE THV and aortic annuli >29 mm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
